Qin Lin - Concepedia

Author

Qin Lin

First Affiliated Hospital of Xiamen University ORCID

Also Known As

Haojun Chen, L.-Z. Qin, LIN QIN, Lin Qin, Lin, Qin, Q Lin, Q. Lin, QIN LIN, Qin LIN, Qin Lin

282

Publications

Citations

H-Index

130

Concepts

All Affiliations

First Affiliated Hospital of Xiamen University Sun Yat-sen University Sun Yat-sen University Cancer Center Xiamen University Fujian Medical University

About

Qin Lin is an author at First Affiliated Hospital of Xiamen University specializing in oncology, medicine, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	31	2.4K
2	Health Sciences	18	24	2.1K
3	Engineering	6	6	199
4	Business	1	1	36
5	Management	1	1	36

Qin Lin

103

Publications

6.4K

Citations

H-Index

Page 1

	Year	Citations
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial Zixian Wang, Chengxu Cui, Jun Yao, Cancer Cell	2022	523
Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial Li Zhang, Yan Huang, Shaodong Hong, The Lancet Cisplatin Versus FluorouracilMedicineMetronomic TherapyPathologyCancer Treatment	2016	515
Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer Haojun Chen, Yizhen Pang, Jingxun Wu, European Journal of Nuclear Medicine and Molecular Imaging Positron Emission TomographyOncologic ImagingMedical ImagingPet-mriMetastatic Lesions	2020	515
Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial Yunpeng Yang, Song Qu, Jingao Li, The Lancet Oncology MedicineClinical TrialsImmune Checkpoint InhibitorCamrelizumab Versus PlaceboPharmacotherapy	2021	429
Comparison of <sup>68</sup>Ga-FAPI and <sup>18</sup>F-FDG Uptake in Gastric, Duodenal, and Colorectal Cancers Yizhen Pang, Liang Zhao, Zuoming Luo, Radiology	2020	293
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial Yu‐Pei Chen, Xu Liu, Qin Zhou, The Lancet OncologyAdvanced Nasopharyngeal CarcinomaMetronomic TherapyNasopharyngeal CancerPathology	2021	217
Usefulness of [68Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [18F]FDG PET/CT findings Haojun Chen, Liang Zhao, Dan Ruan, European Journal of Nuclear Medicine and Molecular Imaging Positron Emission TomographyMedical ImagingPet-mriDiagnosisPathology	2020	213
Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [68Ga]Ga-FAPI-04 PET/CT versus MRI and [18F]-FDG PET/CT Wei Guo, Yizhen Pang, Lanlin Yao, European Journal of Nuclear Medicine and Molecular Imaging Positron Emission TomographyImaging BiomarkersHepatologyMedical ImagingHepatocellular Carcinoma	2020	173
Comparing Paclitaxel Plus Fluorouracil Versus Cisplatin Plus Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Cancer: A Randomized, Multicenter, Phase III Clinical Trial Yun Chen, Jinjun Ye, Zhengfei Zhu, Journal of Clinical Oncology	2019	153
Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of<sup>68</sup>Ga-Labeled FAPI Dimer Liang Zhao, Bo Niu, Jianyang Fang, Journal of Nuclear Medicine	2021	147

Page 1